Why do patients experience shivering after an intravenous glutathione infusion?

Shivering After Glutathione Infusion: Infusion Reaction or Systemic Inflammatory Response

Shivering after intravenous glutathione infusion most likely represents a manifestation of an infusion reaction (cytokine release syndrome or hypersensitivity reaction) or systemic inflammatory response syndrome (SIRS), particularly when using unregulated, high-dose glutathione products administered outside clinical settings.

Understanding the Mechanism

The shivering phenomenon occurs through several potential pathways:

Primary Mechanism: Infusion Reaction

Glutathione infusions can trigger cytokine release syndrome (CRS), which manifests with constitutional symptoms including:

• Fever/hyperpyrexia (potentially >41°C)
• Rigors and shivering
• Chills
• Flushing
• Headache

A documented case demonstrated severe SIRS following high-dose IV glutathione (Glutax 75GX DCRP), presenting with shock, hyperpyrexia >41°C, marked leucocytosis (WCC 26 × 10⁹/L), elevated inflammatory markers (CRP 160 mg/L, procalcitonin 28.8 µg/L), and acute liver injury 1. The patient collapsed within one hour of infusion, highlighting the rapid onset typical of infusion reactions.

Contributing Factors

Unregulated product contamination: Many IV glutathione products used for cosmetic purposes lack regulatory approval and may contain endotoxins or contaminants that trigger inflammatory cascades 1, 2.

Supraphysiological dosing: High-dose glutathione in nutritionally compromised patients may create synergistic inflammatory effects 1.

Direct mast cell activation: Similar to other infusion reactions, glutathione may cause direct histamine release, leading to vasodilation, temperature dysregulation, and compensatory shivering 3.

Clinical Recognition Pattern

Distinguish this from routine post-anesthetic shivering by timing and associated features:

Infusion-related shivering characteristics:

• Onset during or within 1-2 hours of glutathione infusion
• Associated symptoms: fever, flushing, urticaria, pruritus, chest discomfort, dyspnea
• May progress to hypotension, tachycardia, or anaphylaxis
• Laboratory abnormalities if severe: leucocytosis, elevated inflammatory markers, liver enzyme elevation 1

Post-anesthetic shivering (for comparison) occurs from hypothermia due to anesthesia, cool operating rooms, and unwarmed fluids—typically without fever or inflammatory markers 4.

Immediate Management Algorithm

Step 1: Assess Severity

Stop the glutathione infusion immediately and maintain IV access 3.

Evaluate for anaphylaxis criteria (any one indicates anaphylaxis):

1. Acute onset with skin/mucosal involvement PLUS respiratory compromise OR hypotension
2. Two or more systems involved (skin, respiratory, cardiovascular, GI) within minutes to hours
3. Hypotension after known allergen exposure

Step 2: Grade the Reaction

Grade 1-2 (Mild-Moderate):

• Flushing, chills, shivering without hemodynamic instability
• Management:
  • Slow or temporarily stop infusion
  • Diphenhydramine 50 mg IV plus ranitidine 50 mg IV 3
  • Consider methylprednisolone 1-2 mg/kg IV 3
  • Monitor vital signs continuously

Grade 3-4 (Severe) or Anaphylaxis:

• Hypotension, respiratory distress, altered consciousness
• Management:
  • Epinephrine 0.3-0.5 mg IM (1:1000) into lateral thigh immediately 3
  • Repeat every 5-15 minutes if needed
  • Aggressive fluid resuscitation: 1-2 L normal saline at 5-10 mL/kg in first 5 minutes 3
  • Diphenhydramine 50 mg IV plus ranitidine 50 mg IV
  • Methylprednisolone 1-2 mg/kg IV every 6 hours
  • Position patient in Trendelenburg if hypotensive 3
  • Oxygen supplementation as needed

Step 3: Post-Reaction Monitoring

• Continuous vital sign monitoring until complete resolution
• 24-hour observation mandatory for severe reactions 3
• Monitor for biphasic reactions (can occur 4-12 hours later)

Critical Safety Concerns

The FDA-approved glutathione products explicitly state "NOT FOR INJECTION OR INTRAVENOUS INFUSION" 5. These products are formulated only for ophthalmic irrigation during surgery, not systemic administration.

The widespread use of IV glutathione for cosmetic skin lightening occurs with:

• No published safety data for chronic IV use 2
• No standardized dosing protocols
• Risk of contaminated products purchased online 2
• Documented severe reactions including Stevens-Johnson Syndrome 6
• Potential hepatotoxicity and anaphylaxis 7

Prevention Strategies

For patients requesting glutathione therapy:

1. Strongly discourage IV glutathione for cosmetic purposes given lack of safety data and regulatory approval 2, 7

2. If oral glutathione is considered (better safety profile):

   • Use pharmaceutical-grade products only
   • Monitor liver function tests
   • Counsel on limited evidence for efficacy 7

3. Never use unregulated products from wellness clinics or online sources 1, 6

Key Clinical Pitfalls

Failure to obtain supplement history: Always ask specifically about IV vitamin/glutathione infusions from wellness centers when evaluating unexplained systemic inflammation 1, 6.

Misattributing symptoms to infection: The marked leucocytosis and elevated procalcitonin in glutathione-induced SIRS can mimic sepsis, leading to unnecessary antibiotics 1.

Underestimating severity: What begins as "just shivering" can rapidly progress to cardiovascular collapse within one hour 1.

Rechallenge attempts: Do not retry glutathione infusion after any grade 3-4 reaction 3.